HER2 Positive Breast Cancer | Peripheral T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Prostate Cancer | Cutaneous T-cell Lymphoma | B Acute Lymphoblastic Leukemia | Triple Negative Breast Cancer | Pancreatic Cancer | Gastric Cancer | Ovarian Cancer | Colorectal Cancer | Cholangiocarcinoma | Sarcoma | Mesothelioma | Melanoma | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PDR001 | |||||||||||||||
trastuzumab | |||||||||||||||
pembrolizumab | |||||||||||||||
blinatumomab | |||||||||||||||
MGD013 | |||||||||||||||
nivolumab | |||||||||||||||
nivolumab + ipilimumab | |||||||||||||||
PD-L1 inhibitor | |||||||||||||||
Immunotherapy |